Cibus Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.13

+0.04 (+3.67%)

As of Nov 14, 10:37 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 78%

Hold 2 22%

Sell 0 0%

Price Target

Analyst Price Target +2,590.3% upside

Low Target $22.94

Average Target $30.40

High Target $39.68

Current Price $1.13

Current
$1.13

Target
$30.40

$22.94 $30.40 avg $39.68

Scenario Analysis

Bear Case

$22.94

1,930.1%

Low target

Base Case

$30.40

+2,590.3%

Avg target

Bull Case

$39.68

+3,411.5%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$4.19

-73.0% from high

52-Week Low

$1.07

+5.6% from low

Target vs 52W High

$30.40

+625.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-12.7%
AMGN Amgen Inc	Hold	42	43%	$190.87	-59.0%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+115.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-18.6%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-92.0%
MRNA Moderna Inc	Hold	31	32%	$149.45	-33.1%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-55.2%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-33.8%